Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Broker tips: Dowlais, Rio Tinto, Dr Martens
(Sharecast News) - Jefferies initiated coverage of Dowlais - which was recently spun off from Melrose Industries - on Monday with a 'buy' rating and 155p price target, offering upside of around 21%. Dowlais comprises GKN Automotive, GKN Powder Metallurgy and GKN Hydrogen, which sat under Melrose ownership since FY18, and were demerged in April.
"We see Dowlais as a high-quality auto supplier with attractive margin enhancement potential as the auto recovery comes, although we do not see it as overly dependent on volumes or cost recovery," Jefferies said.
"There is a strong management team in place that has led GKN Automotive through its improvement phase and as Dowlais transitions from the prior Melrose 'buy, improve, sell' umbrella to a standalone group, we see these businesses enhanced by a greater focus on long-term structural growth, without compromising on the pursuit of best-in-class profitability."
Deutsche Bank upgraded Rio Tinto to 'buy' from 'hold' and lifted the price target to 6,200p from 6,000p.
The bank noted that this was its first upgrade in more than two years.
"With the shares now down more than 20% from the year-to-date high, we see attractive value underpinned by a high quality, cash generative business," it said.
It said consensus has turned progressively more bearish towards Rio over the past three years due to persistent concerns over the iron ore market and company specific ESG and strategy issues.
"We have trimmed back our near-term iron ore prices ($110/115/t in 2023/24 from ~$120/t), but remain more bullish than consensus (DB more than 15% ahead on 2024 EBITDA) and see 30% total return potential on a 12-month basis.)
Barclays cut its price target on Dr Martens on Monday to 175p from 210p.
The bank said: "Dr. Martens has disappointed investors again, and whilst we may be overlooking as yet unannounced problems, brand strength does seem robust."
It said the US distribution centre issues may be sorted, but execution of the US D2C strategy is now critical.
Barclays downgraded its FY24/25 earnings per share estimates by 12/11% taking it 16/13% below Bloomberg consensus.
Barclays maintained its 'overweight' rating.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Doing Business with Fidelity | Diversity, Equity & Inclusion Reports | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.
